[go: up one dir, main page]

Kaye et al., 1986 - Google Patents

The metabolism and kinetics of doxazosin in man, mouse, rat and dog.

Kaye et al., 1986

View PDF
Document ID
16814721763729842295
Author
Kaye B
Cussans N
Faulkner J
Stopher D
Reid J
Publication year
Publication venue
British journal of clinical pharmacology

External Links

Snippet

The metabolic fate of doxazosin was investigated in man, mouse, rat and dog using 14C‐ labelled compound. Bioavailability and pharmacokinetic studies were also conducted with nonlabelled drug, using a specific hplc method. Following both oral and intravenous …
Continue reading at bpspubs.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0493Steroids, e.g. cholesterol, testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines

Similar Documents

Publication Publication Date Title
Kaye et al. The metabolism and kinetics of doxazosin in man, mouse, rat and dog.
Mangner et al. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma
Martin et al. Metabolic studies of salbutamol-3H: A new bronchodilator, in rat, rabbit, dog and man
Jardine et al. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy
DE69620467T2 (en) RADIONUCLIDE MARKING OF VITAMIN B12 AND THEIR COENZYME
Teng et al. Metoclopramide metabolism and determination by high‐pressure liquid chromatography
El Dareer et al. Distribution and Metabolism of Vincristine in Mice, Rats, Dogs, and Monkeys 1, 2, 3
CA1076481A (en) Drug compositions
Tanayama et al. Biotransformation of molsidomine (N-ethoxycarbonyl-3-morpholinosydnonimine), a new anti-anginal agent, in rats
Tremaine et al. Characterization of a carbamic acid ester glucuronide of the secondary amine sertraline.
Philips et al. Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl) thymine and 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)-5-iodocytosine
Drach et al. Species differences in the metabolism of diphenhydramine (Benadryl)
Arcamone et al. Studies on the metabolism of ergoline derivatives: metabolism of nicergoline in man and in animals
Goehl et al. Distribution, biotransformation and excretion of bupivacaine in the rat and the monkey
Grislain et al. The metabolic pathways of tianeptine, a new antidepressant, in healthy volunteers.
Thomas et al. Metabolism of Minoxidil, a New Hypotensive Agent 11: Biotransformation following Oral Administration to Rats, Dogs, and Monkeys
US5208338A (en) Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
Kamm et al. Metabolism of chlorpheniramine-3H by the rat and dog
Stramentinoli et al. Influence of S-adenosyl-L-methionine on irreversible binding of ethynylestradiol to rat liver microsomes, and its implication in bile secretion
Thomas et al. Metabolism of minoxidil, a new hypotensive agent I: Absorption, distribution, and excretion following administration to rats, dogs, and monkeys
Shargel et al. Physiological disposition and metabolism of (3H) bitolterol in man and dog.
Dicarlo et al. Prazepam metabolism by dogs
Gombar et al. Pharmacokinetics, metabolism, and disposition of 6-chloro-2, 3, 4, 5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) in rats and dogs.
Furst Studies on the distribution and excretion of a metabolite of guanethidine in the rat
Wong et al. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog.